TY - JOUR AU - Eshetie, Setegn AU - Alebel, Animut AU - Wagnew, Fasil AU - Geremew, Demeke AU - Fasil, Alebachew AU - Sack, Ulrich PY - 2018 DA - 2018/09/27 TI - Current treatment of multidrug resistant tuberculosis in Ethiopia: an aggregated and individual patients’ data analysis for outcome and effectiveness of the current regimens JO - BMC Infectious Diseases SP - 486 VL - 18 IS - 1 AB - The programmatic management of Multidrug-resistant tuberculosis (MDR-TB) is entirely based on a WHO recommended long-term, 18–24 month lasting treatment regimen. However, growing evidence shows that low treatment success rate and high rates of adverse events are associated with this regimen. Up to date, the MDR-TB treatment outcome is not sufficiently understood in Ethiopia. Therefore, this analysis aimed to determine the pooled estimates of successful (cure, completed, or both), and poor outcomes (death, failure, and lost to follow ups). SN - 1471-2334 UR - https://doi.org/10.1186/s12879-018-3401-5 DO - 10.1186/s12879-018-3401-5 ID - Eshetie2018 ER -